Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit is currently disabled

Nadine Jackson McCleary, M.D.

Concepts (235)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Colonic Neoplasms10202225351.590 Why?
Colorectal Neoplasms15202469661.270 Why?
Gastrointestinal Neoplasms420239570.960 Why?
Rectal Neoplasms3202211830.940 Why?
Fluorouracil8202216520.850 Why?
Antineoplastic Combined Chemotherapy Protocols212025118720.780 Why?
Cancer Care Facilities220244270.680 Why?
Geriatric Assessment4201714220.630 Why?
Electronic Health Records6202448810.620 Why?
Clinical Trials, Phase III as Topic420188780.620 Why?
Mouth Neoplasms120235970.600 Why?
Chemotherapy, Adjuvant10202235520.600 Why?
Early Termination of Clinical Trials12017700.570 Why?
Self-Help Groups120181940.560 Why?
Camptothecin520225990.520 Why?
Adenocarcinoma7202463600.440 Why?
Bone Marrow Neoplasms120141010.430 Why?
Data Collection2201333210.430 Why?
Deoxycytidine420248860.430 Why?
Self Care120188000.420 Why?
Leucovorin620226440.410 Why?
Peripheral Nervous System Diseases320227160.380 Why?
Esophageal Neoplasms4202416610.360 Why?
Neoplasms112025223500.350 Why?
Pancreatic Neoplasms7202454460.340 Why?
Organoplatinum Compounds520194060.320 Why?
Age Factors82025184010.310 Why?
Randomized Controlled Trials as Topic52018103930.280 Why?
Aged, 80 and over192025595480.270 Why?
Stomach Neoplasms3202414810.270 Why?
Quality Improvement2201838540.260 Why?
Patient Participation3202014440.250 Why?
Aged3720251713190.250 Why?
HSP90 Heat-Shock Proteins220204220.230 Why?
Electronics220223160.220 Why?
Neoplasm Staging102019112170.220 Why?
Neuroendocrine Tumors220256590.220 Why?
Neoplasm Metastasis6202448920.210 Why?
Liver Neoplasms3201443570.210 Why?
Middle Aged3420252232330.210 Why?
Research Design2202262100.210 Why?
Humans6320257670400.200 Why?
Male3920253642030.200 Why?
Quality of Life62024134850.200 Why?
Triazoles220209030.190 Why?
Communication Barriers220224190.190 Why?
Antineoplastic Agents62022136500.190 Why?
Female3920253966600.180 Why?
Esophagogastric Junction220243500.180 Why?
Disease-Free Survival9201468440.180 Why?
Adult2620252233170.170 Why?
Anus Neoplasms120243360.170 Why?
Neoplasms, Unknown Primary120201020.170 Why?
Patient Education as Topic2202023370.150 Why?
Interleukin-1beta1202410270.150 Why?
Patient Selection1201042560.150 Why?
Neutropenia120238920.150 Why?
Palliative Care4202536410.140 Why?
Patient Acceptance of Health Care2202432320.140 Why?
Focus Groups2202414600.130 Why?
Feasibility Studies3202353110.130 Why?
Diagnostic Techniques and Procedures120182160.130 Why?
Medical Oncology3202323410.130 Why?
Sleep Initiation and Maintenance Disorders1202511070.120 Why?
Anemia, Myelophthisic1201460.120 Why?
Prognosis82020299630.120 Why?
Tumor Lysis Syndrome12014370.120 Why?
Comorbidity22022105820.110 Why?
Emigrants and Immigrants120205500.110 Why?
Cholecalciferol120195580.110 Why?
Antimetabolites, Antineoplastic120176450.110 Why?
Leukemia1202215180.110 Why?
Receptor, erbB-21202425990.110 Why?
Disseminated Intravascular Coagulation120141870.110 Why?
Tegafur12013400.110 Why?
Life Expectancy1202012480.110 Why?
Minority Groups1202012140.110 Why?
Smoking1201090810.100 Why?
Qualitative Research1202431390.100 Why?
Phenylurea Compounds220135310.100 Why?
Karnofsky Performance Status120131620.100 Why?
Tumor Microenvironment3202439440.100 Why?
Perception1201812050.100 Why?
Caregivers1202423020.100 Why?
Papillomavirus Infections1202416390.100 Why?
Carcinoma, Pancreatic Ductal2202417590.100 Why?
Treatment Outcome112024652950.090 Why?
Diabetic Retinopathy1202013000.090 Why?
Carcinoma, Hepatocellular2201423300.090 Why?
CpG Islands1201512060.090 Why?
Gene Expression Profiling2201895320.090 Why?
Decision Support Techniques1202120060.090 Why?
Vitamins1201916390.090 Why?
Proto-Oncogene Proteins B-raf3202320580.090 Why?
Informed Consent1201710100.090 Why?
Hydroxychloroquine120144270.090 Why?
Food Hypersensitivity120187340.080 Why?
Survival Rate32019128230.080 Why?
Fatal Outcome1201418360.080 Why?
Software1202344720.080 Why?
Patient-Centered Care1201914440.080 Why?
Sirolimus2201315390.080 Why?
Carcinoma, Squamous Cell1202440490.070 Why?
Colectomy120136960.070 Why?
Safety1201211570.070 Why?
Quinolines120137700.070 Why?
Genomics2202359240.070 Why?
Paclitaxel2202417280.070 Why?
Quinazolines1201313690.070 Why?
Case-Control Studies22015222540.070 Why?
Autophagy1201413470.060 Why?
Dietary Supplements1201934460.060 Why?
Survival Analysis22021100920.060 Why?
Practice Guidelines as Topic2202174350.060 Why?
Receptor Protein-Tyrosine Kinases1201316210.060 Why?
Physician-Patient Relations1201832660.060 Why?
Risk Assessment42020242990.060 Why?
Combined Modality Therapy1201785350.060 Why?
Mass Screening1202054560.060 Why?
Infusions, Intravenous1200922270.060 Why?
Quality of Health Care1201943060.060 Why?
Physicians2202145930.060 Why?
Melanoma1202357020.060 Why?
Phosphatidylinositol 3-Kinases1201328830.060 Why?
Mutation42023302110.060 Why?
Multiple Myeloma1202251860.060 Why?
TOR Serine-Threonine Kinases1201320610.060 Why?
Genetic Variation1201866110.050 Why?
Somatostatin120254580.050 Why?
Drug Resistance, Neoplasm2202053320.050 Why?
Kaplan-Meier Estimate4201365130.050 Why?
Vascular Endothelial Growth Factor A1201335110.050 Why?
Hypesthesia120211060.050 Why?
National Cancer Institute (U.S.)120223000.050 Why?
Pyridines1201328900.050 Why?
DNA Methylation1201544260.050 Why?
Administration, Oral1200940260.050 Why?
Prospective Studies32024548860.040 Why?
Granulocyte Colony-Stimulating Factor120236310.040 Why?
Pyrimidinones120233850.040 Why?
Multimedia12020760.040 Why?
Mitogen-Activated Protein Kinase Kinases120236350.040 Why?
Proportional Hazards Models42019125360.040 Why?
Sulfonamides1200919820.040 Why?
Decision Making1201339510.040 Why?
Pyrazoles1200920280.040 Why?
Physician Assistants120211900.040 Why?
Corylus1201830.040 Why?
Retrospective Studies52024816590.040 Why?
Cell Proliferation12014104550.040 Why?
Penaeidae12018220.040 Why?
Smoking Cessation1201020850.040 Why?
Molecular Diagnostic Techniques120236150.040 Why?
Positron-Emission Tomography1201465500.040 Why?
Nurse Practitioners120212710.040 Why?
Databases, Factual1201380680.040 Why?
Pyridones120238190.040 Why?
Recurrence1201085040.040 Why?
Age of Onset1202433440.030 Why?
Pamphlets12017710.030 Why?
Patients120239080.030 Why?
Culture120206220.030 Why?
Eggs120181820.030 Why?
Odds Ratio2202396600.030 Why?
Leukocytes, Mononuclear1202318540.030 Why?
Health Services Needs and Demand1202414050.030 Why?
Death120206850.030 Why?
Follow-Up Studies22019393170.030 Why?
Young Adult22021599800.030 Why?
Clinical Trials, Phase II as Topic120186380.030 Why?
Canada1202021270.030 Why?
Milk120184370.030 Why?
Double-Blind Method22019124510.030 Why?
Recombinant Proteins1202365070.030 Why?
Multivariate Analysis22019120690.030 Why?
Interviews as Topic1202027410.030 Why?
Protein Kinase Inhibitors2202356930.020 Why?
Adolescent32021890460.020 Why?
Video Recording120179770.020 Why?
Neoplasm Recurrence, Local1201094100.020 Why?
MAP Kinase Signaling System1201814920.020 Why?
Language1202015500.020 Why?
Lymphatic Metastasis1201929000.020 Why?
Massachusetts1202488900.020 Why?
Tomography, X-Ray Computed12014207410.020 Why?
Sex Factors12025106220.020 Why?
Niacinamide120134170.020 Why?
Medical Record Linkage120122860.020 Why?
CD8-Positive T-Lymphocytes1202446480.020 Why?
Guideline Adherence1202122320.020 Why?
Maximum Tolerated Dose120138960.020 Why?
Sequence Analysis, RNA1201820400.020 Why?
Patient Compliance1202026970.020 Why?
Self Report1202137730.020 Why?
DNA1202472100.020 Why?
Microsatellite Instability120137260.020 Why?
Signal Transduction12013236210.020 Why?
Germ-Line Mutation1201818850.020 Why?
Gene Expression Regulation, Neoplastic2201886280.020 Why?
Gene Regulatory Networks1201817520.020 Why?
Vascular Endothelial Growth Factor Receptor-1120135590.020 Why?
Class I Phosphatidylinositol 3-Kinases120139040.020 Why?
Microtubule-Associated Proteins1201410740.020 Why?
Evidence-Based Medicine1202137000.020 Why?
DNA Repair1201820500.020 Why?
ras Proteins1201310540.020 Why?
Prevalence12025158510.020 Why?
SEER Program1201214440.020 Why?
Dose-Response Relationship, Drug12019107480.020 Why?
Socioeconomic Factors1202078480.020 Why?
Clinical Trials as Topic1202280480.020 Why?
Lymphocytes1201426050.020 Why?
Liver Diseases1201413040.020 Why?
Proto-Oncogene Proteins p21(ras)1201317610.020 Why?
Vitamin D1201933120.020 Why?
Cost-Benefit Analysis1201855370.010 Why?
Analysis of Variance1201362150.010 Why?
Mice, Inbred C57BL12023223610.010 Why?
Longitudinal Studies12021147660.010 Why?
Polymerase Chain Reaction1201360670.010 Why?
Delivery of Health Care1202253630.010 Why?
Severity of Illness Index12021159250.010 Why?
Risk Factors12010748860.010 Why?
Animals320231689650.010 Why?
Mice22023819120.010 Why?
Proto-Oncogene Proteins1201345220.010 Why?
Neoplasm Proteins1201335990.010 Why?
Algorithms12021140980.010 Why?
United States22022729710.010 Why?
Cohort Studies12022417180.010 Why?
Liver1201475780.010 Why?
Predictive Value of Tests12013154240.010 Why?
Diabetes Mellitus, Type 212020122500.010 Why?
Disease Progression12013136460.010 Why?
Medicare1201268130.010 Why?
McCleary's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (235)
Explore
_
Co-Authors (114)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.